Schedule 13G ownership disclosure

UNITED THERAPEUTICS CORP DEL COM

Security class unavailable · CUSIP: 91307C102

Event date: 2022-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,569,263
Percent of class
5.6400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000846087-23-000187
Form type
SC 13G
Filer
UNITED THERAPEUTICS Corp
CIK
CIK 1082554
Filed
Feb 06, 2023
Reporting period
Dec 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub